Six years ago, everything changed for hematologist Dr. Gerald Soff. Shortly before his 60th birthday, after several months of feeling progressively more fatigued, he realized something was wrong so he completed a panel of routine blood tests. The results pointed him in the direction of multiple myeloma, a deadly form of cancer in the bone marrow. A friend and colleague confirmed the diagnosis. After nine months of chemotherapy and a bone marrow transplant, he was declared cancer-free and is now celebrating six years since his diagnosis. Research by Nobel Prize laureates Aaron Ciechanover and Avram Hershko, two Israeli scientists supported by ICRF, as well as their American colleague Irwin Rose paged the way for his treatment. These brilliant scientists discovered the “ubiquitin proteasome pathway” – setting the stage for the breakthrough class of drugs that have granted a second life to myeloma patients throughout the world.

Now, Dr. Soff, a member of both the ICRF New York and International Board of Trustees, would like to pay it forward by establishing the Soff Family and Friends Fund. The goal of this initiative is to raise $150,000 to support a three-year Career Development Award for a new Israeli cancer scientist embarking on their career. Once funding is achieved, a candidate from one of the fundable grant applications will be selected.

Please join Dr. Gerald Soff in making a difference.

Read a letter from Dr. Soff.

Dr. Soff discusses his cancer journey, his connection to ICRF, and the Soff Family and Friends Fund.

To donate by mail:

Israel Cancer Research Fund
The Soff Family and Friends Fund
P.O. Box 36, Hartsdale, NY 10530

For any questions, please contact:

Alan Herman
212-969-9800, ext. 225
[email protected]